Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G HALE

Showing results (251-260 of 354) with videos related to

Pageof 36
Sort By:
Tissue Antigens|August 17, 2005
Epitope analysis of immunoglobulins against gp20, a GPI-anchored protein of the human sperm surface homologous to leukocyte antigen CD52F Flori, C Della Giovampaola, R Focarelli, et al.
The New England Journal of Medicine|July 26, 1990
Monoclonal-antibody therapy in systemic vasculitisP W Mathieson, S P Cobbold, G Hale, et al.
Transplantation Proceedings|February 1, 1987
Allogeneic bone marrow transplantation without graft-v-host disease: true tolerance of graft against the host through depletion of donor T lymphocytes pregrafting in malignant and nonmalignant disordersS Slavin, R Or, E Naparstek, et al.
Biomedical Materials (Bristol, England)|March 30, 2012
Injectable reactive biocomposites for bone healing in critical-size rabbit calvarial defectsJerald E Dumas, Pamela B BrownBaer, Edna M Prieto, et al.
Bone Marrow Transplantation|March 21, 2000
The effect of the serotherapy regimen used and the marrow cell dose received on rejection, graft-versus-host disease and outcome following unrelated donor bone marrow transplantation for leukaemiaJ L Byrne, C Stainer, G Cull, et al.
Clinical Immunology (Orlando, Fla.)|October 21, 1999
Anti-adhesion molecule therapy as an interventional strategy for autoimmune inflammationC M Lockwood, J D Elliott, L Brettman, et al.
Clinical and Experimental Immunology|September 30, 2000
Local bioactive tumour necrosis factor (TNF) in corneal allotransplantationS A Rayner, W J King, R M Comer, et al.
Human Immunology|April 11, 2001
Effect of HLA class I or class II incompatibility in pediatric marrow transplantation from unrelated and related donorsW H Leung, V Turner, S L Richardson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 27, 1999
Elimination of the immunogenicity of therapeutic antibodiesL K Gilliland, L A Walsh, M R Frewin, et al.
Lancet (London, England)|September 1, 1984
Elimination of graft-versus-host disease by in-vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (CAMPATH-1)H Waldmann, A Polliak, G Hale, et al.
Pageof 36

Showing results (251-260 of 354) with videos related to

Sort By:
Pageof 36
Tissue Antigens|August 17, 2005
Epitope analysis of immunoglobulins against gp20, a GPI-anchored protein of the human sperm surface homologous to leukocyte antigen CD52F Flori, C Della Giovampaola, R Focarelli, et al.
The New England Journal of Medicine|July 26, 1990
Monoclonal-antibody therapy in systemic vasculitisP W Mathieson, S P Cobbold, G Hale, et al.
Transplantation Proceedings|February 1, 1987
Allogeneic bone marrow transplantation without graft-v-host disease: true tolerance of graft against the host through depletion of donor T lymphocytes pregrafting in malignant and nonmalignant disordersS Slavin, R Or, E Naparstek, et al.
Biomedical Materials (Bristol, England)|March 30, 2012
Injectable reactive biocomposites for bone healing in critical-size rabbit calvarial defectsJerald E Dumas, Pamela B BrownBaer, Edna M Prieto, et al.
Bone Marrow Transplantation|March 21, 2000
The effect of the serotherapy regimen used and the marrow cell dose received on rejection, graft-versus-host disease and outcome following unrelated donor bone marrow transplantation for leukaemiaJ L Byrne, C Stainer, G Cull, et al.
Clinical Immunology (Orlando, Fla.)|October 21, 1999
Anti-adhesion molecule therapy as an interventional strategy for autoimmune inflammationC M Lockwood, J D Elliott, L Brettman, et al.
Clinical and Experimental Immunology|September 30, 2000
Local bioactive tumour necrosis factor (TNF) in corneal allotransplantationS A Rayner, W J King, R M Comer, et al.
Human Immunology|April 11, 2001
Effect of HLA class I or class II incompatibility in pediatric marrow transplantation from unrelated and related donorsW H Leung, V Turner, S L Richardson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 27, 1999
Elimination of the immunogenicity of therapeutic antibodiesL K Gilliland, L A Walsh, M R Frewin, et al.
Lancet (London, England)|September 1, 1984
Elimination of graft-versus-host disease by in-vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (CAMPATH-1)H Waldmann, A Polliak, G Hale, et al.
Pageof 36